Medical device and health tech marketing: why physicians ignore your pitch, and what changes their mind

Medical device and health technology companies tend to market to physicians the way they would market to any sophisticated buyer: a clear value proposition, evidence, a demo, a pilot. The material is often good. The adoption is often terrible. The gap between the two is the subject of this piece, because it is rarely a marketing execution problem and almost always a positioning and go-to-market problem.

How physicians actually evaluate a new tool

Clinicians do not adopt a tool because it is better. They adopt it because it is better and it does not cost them anything they cannot afford: time in a fifteen-minute visit, a step in a workflow that already barely works, credibility with colleagues if it fails, or attention on the one day it matters. A tool that is clinically superior and workflow-hostile loses to a worse tool that fits.

Marketing built by people who have not sat inside a clinic day cannot see this, and the result is a pitch that answers a question the physician is not asking. The physician’s question is not “is this good?” It is “what does this do to my Tuesday?”

Why adoption stalls after the demo

The demo is optimized for the decision-maker, who is frequently not the user. The pilot lands on clinicians who were not in the room, have not been told why this matters to them, and abandon it by week three because the workflow integration was a slide rather than a reality. The company concludes it has a sales problem. It has a positioning problem: the value was framed for the buyer, and the user was never given a reason.

Founders are too close to hear how it lands

The more sophisticated the product, the harder it is to explain, and the people who built it are the least able to hear what the market hears. A description that is precise to the engineering team is noise to a hospital administrator and irrelevant to a clinician. One of the most valuable things an outside strategist does for a health technology company is translate: find the one sentence a buyer can repeat and the one benefit a clinician will feel, and make the entire go-to-market consistent with both.

What a go-to-market strategy for a device or health tech company has to include

A position the market can hold onto. What this is, who it is for, and what problem it solves better than anything else, in language a non-engineer repeats accurately after hearing it once.

Separate messaging for the buyer and the user. The administrator is buying outcomes and cost. The clinician is being asked to change how they work. Those are two audiences, two arguments, and one product.

Clinical credibility that is real. Physician advisors and expert sources who actually use the category, positioned as credible rather than as endorsements. Earned media and thought leadership described honestly: coverage depends on editorial decisions nobody controls.

Launch sequencing that respects the workflow. Pre-launch infrastructure, a pilot designed around the people who will use the tool, and post-launch analysis that treats abandonment as data rather than failure.

Partnerships. Professional organizations, conferences, and the clinicians and creators whose audiences are the exact people the company needs, evaluated for fit rather than reach.

The honest caveat

None of this substitutes for a product that works. What it does is stop a product that works from failing for reasons that have nothing to do with the product, which is the way most health technology companies actually fail.

Why Studio Germina

Studio Germina is a growth, brand, and commercialization consultancy for healthcare businesses, experts, and creators, and founders and emerging organizations are one of the four kinds of client it exists for. Go-to-market for medical device and health technology companies is not an adjacent service here; it is the founder’s direct experience.

You are the medical expert. We are the marketing and business experts. That is the whole arrangement, and it is a partnership rather than a vendor relationship. You keep doing the part only you can do: the clinical work, the answers, the teaching, the content people trust. We take the part you never wanted: positioning, marketing, the deals, the contracts, the pricing, the follow-up, and the reporting that proves it worked.

The hours you already spend online answering questions and posting useful content are real work. You would happily do it for free, and most clinicians do. We make sure that time gets paid for, and paid properly, without turning you into a salesperson. And we select the opportunities we bring you: every deal, campaign, and partnership has to line up with your brand, your ethics, your morals, and your vision for the work. If it does not, we say no on your behalf.

We start with positioning and commercialization, not with campaigns. A message the market cannot hold onto will not be fixed by more marketing, and we say so before recommending any.

We understand both sides. The founder led growth, go-to-market, positioning, enterprise marketing, commercialization, and international expansion across the United States, Europe, and Latin America at a clinical AI company, and led brand, communications, and PR inside a healthcare organization with more than 230 providers. We know what a clinic day does to a product roadmap because we have been on both sides of it.

We say no. If the go-to-market problem is actually a product-workflow problem, we will tell you, because a launch plan cannot fix it.

You get the reasoning, in writing, and you work directly with the person who did the thinking.

That is why founders who have been through an agency that produced beautiful material and no adoption come here, and why we are the better choice for a health company that needs the market to understand what it built. Book a consultation. The healthcare marketing consultant page describes fractional growth leadership and go-to-market engagements in more depth.